GALDERMA GROUP AG (GALDY) Stock

NYSE: GALDYHealthcare company in the specialty & generic drug manufacturers industry, based in Zug, USA.

GALDERMA GROUP stock price chart

GALDY interactive chart →

GALDY stock quote & key statistics

GALDERMA GROUP earnings per share

Income →
Earnings per share

GALDERMA GROUP revenue & net income

Income →
RevenueNet income

GALDERMA GROUP annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$5.24B$613.0M—
FY2024$4.44B$231.0M—
FY2023$4.12B-$57.0M—
FY2022$3.82B-$98.5M—
FY2021$3.44B-$154.3M—

Fiscal year ending December 31. Source: company filings via EODHD.

About GALDERMA GROUP AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

GALDERMA GROUP stock FAQ

What is the GALDERMA GROUP stock ticker symbol?

GALDERMA GROUP AG trades on the NYSE under the ticker symbol GALDY.

What sector and industry is GALDERMA GROUP in?

GALDERMA GROUP AG is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

How many employees does GALDERMA GROUP have?

GALDERMA GROUP AG has about 7,676 full-time employees.

What were GALDERMA GROUP's revenue and earnings last fiscal year?

GALDERMA GROUP reported revenue of $5.24B and net income of $613.0M in fiscal 2025. Revenue grew 18.0% from the prior year.

Drug Manufacturers - Specialty & Generic stocks

All Healthcare stocks →